Podocyte injury and targeting therapy: An update

Current Opinion in Nephrology and Hypertension

Volumn 15, Issue 1, 2006, Pages 1-7

  Durvasula, Raghu V ^a   Shankland, Stuart J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Foot process effacement; Glomerular disease; Podocyte; Proteinuria; Slit diaphragm

Indexed keywords

ACTIN; B7 ANTIGEN; CALCITRIOL; CATHEPSIN L; CD2 ASSOCIATED PROTEIN; CYCLIN DEPENDENT KINASE 5; DYSTROGLYCAN; GLUCOCORTICOID; NEPHRIN; PODOCALYXIN; RETINOIC ACID; SYNAPTOPODIN; VITAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SIALOGLYCOPROTEIN;

CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL SURVIVAL; DRUG TARGETING; EPITHELIUM CELL; GENE DISRUPTION; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; CYTOSKELETON; DRUG EFFECT; KIDNEY DISEASE; METABOLISM; PATHOLOGY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CYTOSKELETON; GLOMERULAR BASEMENT MEMBRANE; HUMANS; KIDNEY DISEASES; PODOCYTES; SIALOGLYCOPROTEINS;

EID: 33645389118     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mnh.0000199012.79670.0b     Document Type: Review

References (50)

1. Kriz W, Gretz N, Lemley KV. Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 1998; 54:687-697.
2. Liu G, Kaw B, Kurfis J, et al. Neph1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability. J Clin Invest 2003; 112:209-221.
3. Topham PS, Kawachi H, Haydar SA, et al. Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. J Clin Invest 1999; 104:1559-1566.
4. Smoyer WE, Mundel P. Regulation of podocyte structure during the development of nephrotic syndrome. J Mol Med 1998; 76:172-183.
5. Wartiovaara J, Ofverstedt LG, Khoshnoodi J, et al. Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography. J Clin Invest 2004; 114:1475-1483. Using electron tomography, this novel study provides new insight into the integral role of the transmembrane protein nephrin in maintaining the porous structure of the slit diaphragm.
6. Roselli S, Heidet L, Sich M, et al. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 2004; 24:550-560. By generating a podocin-deficient mouse strain and characterizing the resultant renal phenotype, this study demonstrates that podocin is essential to the proper assembly of the slit diaphragm.
7. Pereira AC, Pereira AB, Mota GF, et al. NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int 2004; 65:1026-1030.
8. Benzing T. Signaling at the slit diaphragm. J Am Soc Nephrol 2004; 15:1382-1391. This paper provides a comprehensive review on the role of the slit diaphragm as a signal transduction complex.
9. Yu CC, Yen TS, Lowell CA, et al. Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn. Curr Biol 2001; 11:34-38.
10. Verma R, Wharram B, Kovari I, et al. Fyn binds to and phosphorylates the kidney slit diaphragm component nephrin. J Biol Chem 2003; 278:20716-20723.
11. Li H, Lemay S, Aoudjit L, et al. SRC-family kinase Fyn phosphorylates the cytoplasmic domain of nephrin and modulates its interaction with podocin. J Am Soc Nephrol 2004; 15:3006-3015.
12. Huber TB, Hartleben B, Kim J, et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 2003; 23:4917-4928.
13. Foster RR, Saleem MA, Mathieson PW, et al. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 2005; 288:F48-F57.
14. Schiffer M, Mundel P, Shaw AS, et al. A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis. J Biol Chem 2004; 279:37004-37012. This study demonstrates a novel role for CD2AP in mediating TGF-β-induced apoptosis of podocytes in vitro and in vivo.
15. Winn MP, Conlon PJ, Lynn KL, et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308:1801-1804. This study identifies a specific mutation in the calcium channel TRPC6 and raising the novel hypothesis that a primary defect in calcium signaling may promote podocyte injury.
16. Reiser J, Polu KR, Moller CC, et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005; 37:739-744. This study makes the novel observation that TRPC6 is a component of the slit diaphragm complex and identifies additional kindreds of familial FSGS with specific mutations in this calcium channel.
17. Kojima K, Davidovits A, Poczewski H, et al. Podocyte flattening and disorder of glomerular basement membrane are associated with splitting of dystroglycan - matrix interaction. J Am Soc Nephrol 2004; 15:2079-2089.
18. Kreidberg JA. Functions of alpha3beta1 integrin. Curr Opin Cell Biol 2000; 12:548-553.
19. de Paulo V, Teixeira C, Blattner SM, et al. Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int 2005; 67:514-523.
20. Petermann AT, Pippin J, Krofft R, et al. Viable podocytes detach in experimental diabetic nephropathy: potential mechanism underlying glomerulosclerosis. Nephron Exp Nephrol 2004; 98:e114-e123.
21. Petermann AT, Krofft R, Blonski M, et al. Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int 2003; 64:1222-1231.
22. Vogelmann SU, Nelson WJ, Myers BD, et al. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 2003; 285:F40-F48.
23. Gao SY, Li CY, Chen J, et al. Rho-ROCK signal pathway regulates microtubule-based process formation of cultured podocytes: inhibition of ROCK promoted process elongation. Nephron Exp Nephrol 2004; 97:e49-e61.
24. Michaud JL, Lemieux LI, Dube M, et al. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4. J Am Soc Nephrol 2003; 14:1200-1211.
25. Kos CH, Le TC, Sinha S, et al. Mice deficient in alpha-actinin-4 have severe glomerular disease. J Clin Invest 2003; 111:1683-1690.
26. Asanuma K, Kim K, Oh J, et al. Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest 2005; 115:1188-1198. This study identifies a novel role for synaptopodin to induce stress fiber formation in podocytes through the regulation of the actin-bundling activity of α-actinin.
27. Griffin SV, Hiromura K, Pippin J, et al. Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology. Am J Pathol 2004; 165:1175-1185. This study characterizes expression of CDK5 during glomerulogenesis and identifies a novel role for CDK5 in preserving the differentiated phenotype of the podocyte through the regulation of cytoskeletal structure.
28. Reiser J, Oh J, Shirato I, et al. Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin. J Biol Chem 2004; 279:34827-34832.
29. Ciani L, Patel A, Allen ND, et al. Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype. Mol Cell Biol 2003; 23:3575-3582.
30. Moeller MJ, Soofi A, Braun GS, et al. Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization. EMBO J 2004; 23:3769-3779.
31. Reiser J, von Gersdorff G, Loos M, et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004; 113:1390-1397. This paper makes the novel observation that the costimulatory molecule B7.1, normally expressed by antigen-presenting cells, is induced in the podocytes following various forms of injury to induce foot process effacement and disruption of the slit diaphragm complex.
32. Srichai MB, Konieczkowski M, Padiyar A, et al. A WT1 co-regulator controls podocyte phenotype by shuttling between adhesion structures and nucleus. J Biol Chem 2004; 279:14398-14408.
33. Orloff MS, Iyengar SK, Winkler CA, et al. Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics 2005; 21:212-221.
34. Takeda T, McQuistan T, Orlando RA, et al. Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J Clin Invest 2001; 108:289-301.
35. Schmieder S, Nagai M, Orlando RA, et al. Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. J Am Soc Nephrol 2004; 15:2289-2298.
36. Hara M, Yanagihara T, Kihara I, et al. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. J Am Soc Nephrol 2005; 16:408-416.
37. Morton MJ, Hutchinson K, Mathieson PW, et al. Human podocytes possess a stretch-sensitive, Ca2+-activated K+ channel: potential implications for the control of glomerular filtration. J Am Soc Nephrol 2004; 15:2981-2987.
38. Petermann AT, Pippin J, Durvasula R, et al. Mechanical stretch induces podocyte hypertrophy in vitro. Kidney Int 2005; 67:157-166.
39. Durvasula RV, Petermann AT, Hiromura K, et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65:30-39. This study demonstrates that mechanical forces activate a local angiotensin system in podocytes by increasing angiotensin II generation and upregulating AT1R levels, providing insight into possible mechanisms of podocyte injury and resultant sclerosis in disease states associated with glomerular capillary hypertension.
40. Hoffmann S, Podlich D, Hahnel B, et al. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004; 15:1475-1487. Overexpression of the AT1R in podocytes leads to the spontaneous development of podocyte injury, porteinuria, and renal insufficiency, supporting a causal role for the chronic activation of the AT1R in the podocyte in mediating development of glomerulosclerosis.
41. Wada T, Pippin JW, Marshall CB, et al. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 2005; 16:2615-2625.
42. Ransom RF, Vega-Warner V, Smoyer WE, et al. Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes. Kidney Int 2005; 67:1275-1285.
43. Griffin SV, Petermann AT, Durvasula RV, et al. Podocyte proliferation and differentiation in glomerular disease: role of cell-cycle regulatory proteins. Nephrol Dial Transplant 2003; 18 (Suppl 6):vi8-vi13.
44. Moeller MJ, Soofi A, Hartmann I, et al. Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 2004; 15:61-67. Generating a mouse model to constitutively drive β-galactosidase expression by the nephrin promoter, the authors of this study were able to confirm the contribution of proliferating cells of podocyte origin in the development of crescentic disease.
45. Petermann A, Hiromura K, Pippin J, et al. Differential expression of d-type cyclins in podocytes in vitro and in vivo. Am J Pathol 2004; 164:1417-1424.
46. Griffin SV, Krofft RD, Pippin JW, et al. Limitation of podocyte proliferation improves renal function in experimental crescentic glomerulonephritis. Kidney Int 2005; 67:977-986.
47. Gherardi D, D'Agati V, Chu TH, et al. Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202. J Am Soc Nephrol 2004; 15:1212-1222.
48. Vaughan MR, Pippin JW, Griffin SV, et al. ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo. Kidney Int 2005; 68:133-144.
49. Moreno-Manzano V, Mampaso F, Sepulveda-Munoz JC, et al. Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Br J Pharmacol 2003; 139:823-831.
50. Kuhlmann A, Haas CS, Gross ML, et al. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol 2004; 286:F526-F533.